Modern molecular-based diagnostic tools have elucidated the phenotypic and molecular heterogeneity of breast cancer (BCa) [8], including luminal A, luminal B, basal-like, and human epidermal growth factor receptor 2 (HER2) types. The gene discussed is ERBB2; the disease is breast carcinoma.